95 related articles for article (PubMed ID: 15182642)
41. TRAIL in the airways.
Robertson NM; Rosemiller M; Lindemeyer RG; Steplewski A; Zangrilli JG; Litwack G
Vitam Horm; 2004; 67():149-67. PubMed ID: 15110176
[TBL] [Abstract][Full Text] [Related]
42. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
[TBL] [Abstract][Full Text] [Related]
43. Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells.
Earel JK; VanOosten RL; Griffith TS
Cancer Res; 2006 Jan; 66(1):499-507. PubMed ID: 16397266
[TBL] [Abstract][Full Text] [Related]
44. TRAIL: Activation of ERK1/2 Protects Cells Against Apoptosis.
Cremer M
Cancer Invest; 2005; 23(7):651. PubMed ID: 16305993
[No Abstract] [Full Text] [Related]
45. TRAIL gene reorganizes the cytoskeleton and decreases the motility of human leukemic Jurkat cells.
Jiang Y; Chen K; Tang Z; Zeng Z; Yao W; Sun D; Ka W; He D; Wen Z; Chien S
Cell Motil Cytoskeleton; 2006 Aug; 63(8):471-82. PubMed ID: 16767747
[TBL] [Abstract][Full Text] [Related]
46. The TRAIL to arthritis.
Tsokos GC; Tsokos M
J Clin Invest; 2003 Nov; 112(9):1315-7. PubMed ID: 14597758
[TBL] [Abstract][Full Text] [Related]
47. Characterization and expression analysis of TNF-related apoptosis inducing ligand (TRAIL) in grass carp Ctenopharyngodon idella.
Chang MX; Nie P; Xie HX; Wang GL; Gao Y
Vet Immunol Immunopathol; 2006 Mar; 110(1-2):51-63. PubMed ID: 16216337
[TBL] [Abstract][Full Text] [Related]
48. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
[TBL] [Abstract][Full Text] [Related]
49. Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts.
Cappellini A; Mantovani I; Tazzari PL; Grafone T; Martinelli G; Cocco L; Martelli AM
Int J Mol Med; 2005 Dec; 16(6):1041-8. PubMed ID: 16273284
[TBL] [Abstract][Full Text] [Related]
50. Requirement of c-Jun NH2-terminal kinase activation in interferon-alpha-induced apoptosis through upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells.
Yanase N; Hata K; Shimo K; Hayashida M; Evers BM; Mizuguchi J
Exp Cell Res; 2005 Oct; 310(1):10-21. PubMed ID: 16099454
[TBL] [Abstract][Full Text] [Related]
51. Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand.
Secchiero P; Gonelli A; Carnevale E; Corallini F; Rizzardi C; Zacchigna S; Melato M; Zauli G
Neoplasia; 2004; 6(4):364-73. PubMed ID: 15256058
[TBL] [Abstract][Full Text] [Related]
52. Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7.
Bremer E; Samplonius DF; Peipp M; van Genne L; Kroesen BJ; Fey GH; Gramatzki M; de Leij LF; Helfrich W
Cancer Res; 2005 Apr; 65(8):3380-8. PubMed ID: 15833872
[TBL] [Abstract][Full Text] [Related]
53. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.
Shiraishi T; Yoshida T; Nakata S; Horinaka M; Wakada M; Mizutani Y; Miki T; Sakai T
Cancer Res; 2005 Jul; 65(14):6364-70. PubMed ID: 16024639
[TBL] [Abstract][Full Text] [Related]
54. [Construction of recombinant expression vector of IL-24 gene and prokaryotic expression].
Qu SG; Chen M; Zhang XL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):273-5, 279. PubMed ID: 15862137
[TBL] [Abstract][Full Text] [Related]
55. [Construction and expression of prokaryotic expression vector pTWIN1/TRAIL].
Yang WL; Chen SH; Chen YR; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):670-4, 678. PubMed ID: 17037724
[TBL] [Abstract][Full Text] [Related]
56. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
Okuyama S; Komatsuda A; Wakui H; Aiba N; Fujishima N; Iwamoto K; Ohtani H; Sawada K
Nephrol Dial Transplant; 2005 Mar; 20(3):539-44. PubMed ID: 15671071
[TBL] [Abstract][Full Text] [Related]
57. Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L.
Di Pietro R; Zauli G
J Cell Physiol; 2004 Dec; 201(3):331-40. PubMed ID: 15389537
[TBL] [Abstract][Full Text] [Related]
58. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture.
Di Pietro R; Mariggiò MA; Guarnieri S; Sancilio S; Giardinelli A; Di Silvestre S; Consoli A; Zauli G; Pandolfi A
J Cell Biochem; 2006 Mar; 97(4):782-94. PubMed ID: 16229016
[TBL] [Abstract][Full Text] [Related]
59. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells.
Shi RX; Ong CN; Shen HM
Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950
[TBL] [Abstract][Full Text] [Related]
60. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
